Creative solution to finding a meeting space at #JPM23. Who knew the @Macys Union Square dressing room could be so productive? Kudos for the scrappiness and creativity of these guys. #biotech #biotechnology
3
16
1,663
Looking for a new gig? COME WORK WITH US! We're hiring a VP of content and science writing. This person will work closely with yours truly on developing compelling corporate narratives for all of our clients. :-) Here's the listing: lnkd.in/gec5fqCV. #hiring #biotech
2
1
Heidi Chokeir retweeted
To find the best treatment for non-small cell lung cancer (#NSCLC), #BiomarkerTesting shouldn’t be skipped. This test allows doctors to understand your immune system’s ability to fight #cancer before treatment even begins. Talk with your doctor today about testing #PDL1:
I LOVE that we're still learning about basic things like cell division!
For hundreds of years there have only been two main types of cell division in animals, but researchers have identified a new and unexpected kind of cell division that occurs without DNA being replicated. Read the @Nature paper: go.nature.com/3MLLlnN
A new kind of cell division
2
Heidi Chokeir retweeted
In the antibiotics pipeline
We need Antibiotics for CRAB , but Polymyxins,again?!
New Polymyxins w reduced toxicity & greater antimicrobial coverage (CRAB & PSA)
MRX-8:A novel polymyxin B analog
QPX9003(synthetic lipopeptide)
A next-generation,IV-administered synthetic polymyxin
Heidi Chokeir retweeted
Our CEO @paulpetertak was included in @PharmaScrip annual outlook feature sharing his anticipations on the industry at large and within the immuno-oncology space. Read the full piece here: bit.ly/3sZhBNc
Heidi Chokeir retweeted
At Candel we aim to strive for women and young girls to have full and equal access to and participation in #STEM. Happy International Day of Women and Girls in Science! #WomenInSTEM
Heidi Chokeir retweeted
Fascinating work expanding our insights into the pro-inflammatory effects of adenoviral gene constructs, which are used as COVID19 vaccines as well as oncolytic viral immunotherapies: ‘’Adenovirus vaccine vectors activated Vδ2+ γδT…lnkd.in/eyG3TVAr lnkd.in/eKx7rY7a
Heidi Chokeir retweeted
Our CEO Kevin Appelbaum sat down with @GrinsteinJ of @GENBio to discuss the bold vision behind our company – a new way to treat age-old diseases, starting with #type2diabetes. Read the full piece here: genengnews.com/cardiovascula…
You know it’s bad when even the Costco gas is $4.40 a gallon. #gasprices #inflation
Great Op/Ed in @sdut. Such an important conversation that needs to be had, given the global threat of antimicrobial resistance. We need to do better! How do we make the shift? @BARDA @AWG_News @gardp_amr @AMRActionFund @ScottGottliebMD
When I began my career in '80s, I practiced what is now called “antibiotic stewardship”– the right antibiotic to the right patient. But it was “patient stewardship.” We need to reform how best antibiotics are valued and reform how insurance pays for them.sandiegouniontribune.com/opi…
1
Heidi Chokeir retweeted
Congratulations to the @Qpexbio team on publishing on the chemical development for Phase 3 readiness of the ultra-broad spectrum inhibitor QPX7728 that can be delivered IV and orally. @BARDA @AWG_News @gardp_amr @AMRActionFund
Qpex Biopharma reports on an efficient process for manufacture of β-lactamase inhibitor QPX7728, featuring Ni-catalyzed boron insertion and enantioselective cyclopropanation pubs.acs.org/doi/10.1021/acs…
Heidi Chokeir retweeted
#transcript Dr. Steve Worland #eFFECTORTherapeutics Genomics 3.0 pioneer in selective translation regulator inhibitors #STRIs Two #cancer revolutions targeted therapies & #immunotherapies. STRIs 3rd way to compliment one or both of those.#NSCLC #SPAC empoweredpatientradio.com/us…
Heidi Chokeir retweeted
Today, we announced that we earned a $60M milestone from our collaboration with Roche for dosing the first patient in the global Phase 2b PADOVA study of prasinezumab in patients with early Parkinson's disease. Learn more: bit.ly/3ocE45C
Couldn't ask for a more intelligent and passionate scientist to lead the La Jolla Institute for Immunology than my dear friend Erica Ollmann Saphire @EOSaphire !
lji.org/news-events/news/pos…
1
Great piece by @LifeSciVC that reminds us of what lurks underneath the zoom persona -- real people with real pain. Personal Reflection: Empathy In The Workplace lifescivc.com/2021/03/person…
1




















